Please assess the completion status of the following clinical trial:

Trial Title: Inpatient Diabetes on Corticosteroids

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Prior history of diabetes~* Able to provide informed consent~* Receiving corticosteroids while hospitalized of greater than 10 mg/d prednisone or the equivalent of dexamethasone or methylprednisolone~* Expect to be hospitalized for 48 hours~Exclusion Criteria:~* Renal failure with GFR (glomerular filtration rate) \< 30 ml/min/1.73m2~* ALT (alanine aminotransferase) \> 2 times upper normal for laboratory

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 79 Years
- Healthy Volunteers: f

Study Arms:
- NPH with steroid dose (Type: EXPERIMENTAL): Receive NPH with each corticosteroid dose during the study duration (2-5 days).~Low dose corticosteroids High dose corticosteroids Eating and 6a-8p 0.15 units NPH/kg 0.3 units NPH/kg NPO(nothing by mouth) or 8p-6a 0.1 units NPH/kg 0.2 units NPH/kg
- Control - Background and correction insulin (Type: ACTIVE_COMPARATOR): Receive usual care with background insulin and correction factor for duration of study (2-5 days)

Based on this trial design, predict the completion outcome and termination type (if applicable).